Armata Pharmaceuticals Inc. (ARMP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Armata Pharmaceuticals Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$3.29
−5.73% today
Market cap
$130M
Overall quality
25/100
Kronos AI 30-day
+42.5%
8 of 8 simulated paths end higher
Armata Pharmaceuticals Inc. (ARMP) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $130M. It trades at $3.29, down 5.73% today. Its overall quality score is 25 out of 100, ranked against the whole US market. 2 analysts' average target of $17.50 implies +431.9% from today's price. Kronos AI's 30-day forecast is +42.5% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $17.50 |
| Low – high | $15.00 – $20.00 |
| Analysts | 2 |
| Upside to average | +431.9% |
Kronos AI 30-day forecast
| Expected close | $4.97 (+42.5%) |
| Likely range | +33.7% … +64.0% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 19 |
| Solvency | 26 |
| Growth | 30 |
| Overall | 25 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.